Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

ETR/VX1 stock hub

ETR/VX1 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ETR/VX1is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

92.7B

Deutsche Börse Xetra

Market data

Live price

Current market quote for this ticker.

Current price

ETR/VX1

In the news

Latest news · ETR/VX1

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E21.5

P25 12.3P50 15.7P75 20.2

Trailing P/E24.6

P25 16.4P50 20.9P75 30.4

ROE24.2

P25 -6.7P50 8.5P75 17.2

ROIC28.6

P25 -1.7P50 8.5P75 17.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ETR/VX1 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

219

Groups with data

Currency

USD

Showing 219 of 219 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	6,400
Employees Change	700%
Employees Change Percent	12.96
Enterprise value	EUR 83.3B
Exchange	Deutsche Börse Xetra
Financial currency	USD
First seen	2026-05-10
Industry	Biotechnology
Isin	US92532F1003
Last refreshed	2026-05-10
Market cap	EUR 92.7B
Price	EUR 364
Price currency	EUR
Rev Per Employee	1,655,729.91x
Sector	Healthcare
Sic	2836
Symbol	etr/VX1
Website	https://www.vrtx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.06%
EV Earnings	22.15x
EV/EBIT	20.45x
EV/EBITDA	18.68x
EV/FCF	25.9x
EV/Sales	8.03x
FCF yield	3.47%
Forward P/E	21.46x
P/B ratio	5.52x
P/E ratio	24.63x
P/S ratio	8.75x
PE Ratio10 Y	50.67x
PE Ratio3 Y	27.83x
PE Ratio5 Y	25.86x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	39.25%
EBITDA Margin	40.77%
FCF margin	30.37%
Gross margin	54.39%
Gross Profit	EUR 5.8B
Gross Profit Growth	16.02%
Gross Profit Growth Q	14.36%
Gross Profit Growth3 Y	6.91%
Gross Profit Growth5 Y	11.76%
Net Income	EUR 3.8B
Net Income Growth Q	59.59%
Net Income Growth Quarters	4%
Net Income Growth Years	1%
Net Income Growth3 Y	10%
Net Income Growth5 Y	9.45%
Pretax Margin	42.28%
Profit Margin	35.51%
Profit Per Employee	EUR 587,907
Profitable Years	1
ROA	12.14
Roa5y	14.82
ROCE	21.21
ROE	24.2
Roe5y	19
ROIC	28.57
Roic5y	37.75

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-5.51%
Cagr3y	4.87%
Cagr5y	15.45%
EPS Growth Q	61.45
EPS Growth Quarters	4
EPS Growth Years	1
EPS Growth3 Y	10.35
EPS Growth5 Y	9.96
FCF Growth Q	66.37%
FCF Growth3 Y	-1.57%
FCF Growth5 Y	4.01%
OCF Growth Q	74.39%
OCF Growth3 Y	1.35%
OCF Growth5 Y	4.77%
Revenue Growth	10.08x
Revenue Growth Q	7.82x
Revenue Growth Quarters	32x
Revenue Growth Years	11x
Revenue Growth3 Y	9.89x
Revenue Growth5 Y	13.75x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.5
Assets	EUR 23B
Cash	EUR 6.3B
Current Assets	EUR 9.9B
Current Liabilities	EUR 3.3B
Debt	EUR 1.7B
Debt EBITDA	EUR 0.38
Debt Equity	EUR 0.1
Debt FCF	EUR 0.54
Equity	EUR 16.8B
Interest Coverage	360.5
Liabilities	EUR 6.2B
Long Term Assets	EUR 13B
Long Term Liabilities	EUR 2.9B
Net Cash	EUR 9.5B
Net Cash By Market Cap	EUR 10.3
Net Cash Growth	13.41%
Net Debt EBITDA	EUR -2.21
Net Debt Equity	EUR -0.57
Net Debt FCF	EUR -2.97
Tangible Book Value	EUR 15.5B
Tangible Book Value Per Share	EUR 60.93
WACC	6.66

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.02
Inventory Turnover	3.56
Net Working Capital	EUR 523M
Quick ratio	2.38
Working Capital	EUR 6.8B
Working Capital Turnover	EUR 1.51

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.15%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-5.51%
200-day SMA	372.9
3Y total return	15.35%
50-day SMA	386.3
50-day SMA vs 200-day SMA	50over200
5Y total return	105.07%
All Time High	489.2
All Time High Change	-25.63%
All Time High Date	2024-11-11
All Time Low	80.5
All Time Low Change	351.93%
All Time Low Date	2017-02-24
ATR	6.55
Beta	0.46
Ch YTD	-7.04
High	365.9
High52	433.3
High52 Date	2026-03-10
High52ch	-16.03%
Low	358.1
Low52	312.7
Low52 Date	2025-08-11
Low52ch	16.36%
Ma50ch	-5.82%
Price vs 200-day SMA	-2.45%
RSI	39.12
RSI Monthly	47.07
RSI Weekly	42.76
Sharpe ratio	-0.13x
Sortino ratio	-0.01
Total Return	0.15%
Tr YTD	-7.04
Tr1m	-1.45%
Tr1w	-0.37%
Tr3m	-9.02%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 4.2B
Operating Income Growth	13.9
Operating Income Growth Q	10.45
Operating Income Growth3 Y	2.39
Operating Income Growth5 Y	9.6
Operating margin	39.25

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	253,010,542%
Net Borrowing	-4,578,994.8
Shares Insiders	0.21%
Shares Institutions	94.43%
Shares Qo Q	0.08%
Shares Yo Y	-0.15%
Short Ratio	3.26

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 2.6B
Average Volume	56.25x
Bv Per Share	66.07
CAPEX	EUR -459.9M
Ch1m	-1.45
Ch1w	-0.37
Ch1y	-5.51
Ch3m	-9.02
Ch3y	15.35
Ch5y	105.1
Ch6m	3.25
Change	0.37%
Change From Open	1.61
Close	362.5
Days Gap	-1.21
Depreciation Amortization	157,805,728.2
Dollar Volume	146,247.6
Earnings Date	2026-05-04
EBIT	EUR 4.2B
EBITDA	EUR 4.3B
EPS	EUR 14.62
F Score	6
FCF	EUR 3.2B
FCF EV Yield	3.86x
Financing CF	-1,838,415,810
Fiscal Year End	December
Founded	1,989
Goodwill	922,582,656
Graham Number	147.99773
Graham Upside	-59.32
Income Tax	EUR 717.6M
Investing CF	-1,146,136,950
Is Primary Listing	0
Last Earnings Date	2026-05-04
Last Report Date	2026-03-31
Last Split Date	2000-08-24
Last Split Type	Forward
Lynch Fair Value	EUR 140
Lynch Upside	-61.63
Ma150	382
Ma150ch	-4.77%
Ma20	368.8
Ma20ch	-1.36%
Net CF	710,752,350
Open	358.1
P FCF Ratio	28.8
P OCF Ratio	25.2
Position In Range	73.72
Ppne	2,792,762,847
Price Date	2026-05-08
Price EBITDA	EUR 21.45
Ptbv Ratio	5.98
Relative Volume	10.91x
Revenue	10,596,671,400x
SBC By Revenue	5.62x
Share Based Comp	595,141,260
Tax By Revenue	6.77x
Tax Rate	16.02%
Tr6m	3.25%
Volume	402
Z Score	11.73

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ETR/VX1 pay a dividend?

Capital-return profile for this ticker.

Performance

ETR/VX1 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ETR/VX1?

Insider, institutional, and short-interest positioning.

Institutional ownership

+94.4%

Share of float held by funds and institutions

Insider ownership

+0.2%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

ETR/VX1 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

39.1

Neutral momentum band

Price vs 200-day MA

-2.5%

50/200-day relationship not available

Beta (5Y)

0.46

Less volatile than the market

Sharpe ratio

-0.13

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ETR/VX1

Hub-level FAQ points readers to the deeper analysis pages.

What is the current etr/VX1 stock rating?

etr/VX1 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full etr/VX1 analysis?

The full report lives at /stocks/etr/VX1/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for etr/VX1?

The latest report frames etr/VX1 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the etr/VX1 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.